Education
About Us
Working with TipRanks
Follow Us
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -22.79M | $ -7.42M | $ -11.36M |
| EBITDA | $ -22.65M | $ -6.65M | $ -9.76M |
| Net Income | $ -20.59M | $ -7.21M | $ -13.56M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 73.66M | $ 9.99M | $ 16.11M |
| Total Assets | $ 77.51M | $ 10.54M | $ 16.76M |
| Total Debt | $ 779.00K | $ 162.00K | $ 262.00K |
| Net Debt | $ -60.86M | $ -9.57M | $ -15.30M |
| Total Liabilities | $ 132.15M | $ 45.34M | $ 44.68M |
| Stockholders' Equity | $ -54.64M | $ -34.80M | $ -27.92M |
| Cash Flow | |||
| Free Cash Flow | $ -18.20M | $ -5.82M | $ -10.54M |
| Operating Cash Flow | $ -18.09M | $ -5.82M | $ -10.54M |
| Investing Cash Flow | $ -12.00M | $ 0.00 | $ -1.00M |
| Financing Cash Flow | $ 81.99M | $ 0.00 | $ 225.00K |